NCT00003192View on ClinicalTrials.gov

Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 31, 1998

Primary Completion Date

February 28, 2002

Study Completion Date

August 31, 2003

Conditions
Esophageal CancerGastric Cancer
Interventions
DRUG

aminocamptothecin

Trial Locations (7)

46617

Michiana Hematology/Oncology P.C., South Bend

60640

Louis A. Weiss Memorial Hospital, Chicago

61602

Oncology/Hematology Associates of Central Illinois, P.C., Peoria

62526

Cancer Care Specialists of Central Illinois, S.C., Decatur

62701

Central Illinois Hematology Oncology Center, Springfield

60637-1470

University of Chicago Cancer Research Center, Chicago

46885-5099

Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Chicago

OTHER

NCT00003192 - Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus | Biotech Hunter | Biotech Hunter